Mirae Asset Global ETFs Holdings
RLAY icon

Mirae Asset Global ETFs Holdings’s Relay Therapeutics RLAY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
94,732
+18,071
+24% +$262K ﹤0.01% 1306
2026
Q1 		$756K Sell
76,661
-18
-0% -$161 ﹤0.01% 1658
2025
Q4 		$647K Buy
76,679
+6,650
+9% +$47.5K ﹤0.01% 1761
2025
Q3 		$365K Sell
70,029
-12,334
-15% -$47K ﹤0.01% 2022
2025
Q2 		$283K Sell
82,363
-1,706
-2% -$5.07K ﹤0.01% 2095
2025
Q1 		$221K Buy
84,069
+5,238
+7% +$20.5K ﹤0.01% 2274
2024
Q4 		$325K Buy
78,831
+17,009
+28% +$92.6K ﹤0.01% 2124
2024
Q3 		$440K Buy
61,822
+5,711
+10% +$42.7K ﹤0.01% 1977
2024
Q2 		$364K Buy
+56,111
New +$383K ﹤0.01% 1967

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RLAY Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Relay Therapeutics (RLAY) stake by 24% in Q2 2026, buying an estimated $262K and bringing the position to 94,732 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Mirae Asset Global ETFs Holdings first reported a position in RLAY in Q2 2024 and has held it in 9 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 94,732 shares of Relay Therapeutics worth $1.79M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 18,071 Relay Therapeutics shares in Q2 2026, an estimated $262K.
  • Relay Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1306 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Relay Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.